REVELIO THERAPEUTICS

Filed: June 18, 2024
Antibodies for scientific and biomedical research purposes; none of the foregoing for use related to nucleic acid sequencing…
Owned by: Revelio Therapeutics, Inc.
Serial Number: 98606663